Cargando…
Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now)
Since the beginning of the COVID-19 epidemic, a possible explanation for the high heterogeneity of infection/mortality rates across involved countries was hinted in the prevalence of tuberculosis vaccination with Bacille Calmette-Guérin (BCG). A systematic review was therefore performed on May 2, 20...
Autores principales: | Riccò, Matteo, Gualerzi, Giovanni, Ranzieri, Silvia, Bragazzi, Nicola Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569626/ https://www.ncbi.nlm.nih.gov/pubmed/32420947 http://dx.doi.org/10.23750/abm.v91i2.9700 |
Ejemplares similares
-
Bacille Calmette-Guérin: An ophthalmic perspective
por: Jain, Manish, et al.
Publicado: (2022) -
Are Bacille Calmette-Guérin Skin Reactions the Most Important Correlates of Bacille Calmette-Guérin’s Specific and Nonspecific Effects?
por: Schaltz-Buchholzer, Frederik
Publicado: (2022) -
Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, Helen
Publicado: (2011) -
Gluteal abscess: An unusual complication of Bacille Calmette-Guérin
por: Buyukoglan, Hakan, et al.
Publicado: (2011) -
Bacille-Calmette-Guerin non-responders: how to manage
por: von Rundstedt, Friedrich-Carl, et al.
Publicado: (2015)